Swallow tablet comprising paracetamol

A non-effervescent dosage form intended to be swallowed directly such as a swallow tablet or capsule formulation comprising a therapeutically effective amount of paracetamol, a pharmaceutically acceptable excipient and an amount of antacid up to 55 mg per unit dose wherein the antacid is sodium bicarbonate or potassium bicarbonate or mixtures thereof with the proviso that the dosage form does not comprise a mixture of paracetamol and citric acid in a proportion of 85:15 to 90:10% w/w, sodium bicarbonate/sodium carbonate and a pharmaceutically acceptable carrier.